» Articles » PMID: 27178763

The Risk of Embryo-endometrium Asynchrony Increases with Maternal Age After Ovarian Stimulation and IVF

Overview
Publisher Elsevier
Date 2016 May 15
PMID 27178763
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

This retrospective cohort analysis examined the effects of maternal age on the incidence of factors associated with embryo-endometrium asynchrony in fresh autologous blastocyst transfer. The study included 1169 routine fresh autologous blastocyst transfers. The main outcome measure was asynchronous transfer defined by delayed (day 6) blastocyst transfer or elevated pre-ovulatory serum progesterone level. Compared with patients younger than 35 years, patients 35 years or older had increased risk of having at least one risk factor for asynchronous transfer, including premature progesterone elevation or delayed blastocyst transfer (RR 1.36; 95% CI 1.24 to 1.50). The older group had increased risk of simultaneously having both risk factors (RR 1.61, 95% CI 1.17 to 2.21) compared with the younger group. In patients younger than 35 years, live birth rate per transfer was 62.9% with day 5 transfer and low progesterone, declining to 27.9% for day 6 transfer combined with elevated progesterone. In patients 35 years or older, live birth rate per transfer was 38.0% with day 5 transfer and low progesterone, declining to 18.1% for day 6 transfer combined with elevated progesterone. Indicators of embryo-endometrium asynchrony increase in prevalence as women age and asynchrony disproportionately decreases birth rates in older patients.

Citing Articles

Do endometrial immune changes with age prior to menopause compromise fertility in women?.

Patel M, Shen Z, Wira C Explor Immunol. 2025; 2(5):677-692.

PMID: 39931230 PMC: 11809571. DOI: 10.37349/ei.2022.00076.


Age-related uterine changes and its association with poor reproductive outcomes: a systematic review and meta-analysis.

Marti-Garcia D, Martinez-Martinez A, Sanz F, Devesa-Peiro A, Sebastian-Leon P, Del Aguila N Reprod Biol Endocrinol. 2024; 22(1):152.

PMID: 39616336 PMC: 11607893. DOI: 10.1186/s12958-024-01323-6.


Immunomodulatory Treatment Impact on IVF Outcomes in KIR AA Genotype: Personalized Fertility Insights.

Seles L, Zaha I, Luncan M, Bodog A, Sachelarie L, Sandor M Medicina (Kaunas). 2024; 60(6).

PMID: 38929565 PMC: 11205848. DOI: 10.3390/medicina60060948.


Predictive models of recurrent implantation failure in patients receiving ART treatment based on clinical features and routine laboratory data.

Fang Q, Qiao Z, Luo L, Bai S, Chen M, Zhang X Reprod Biol Endocrinol. 2024; 22(1):32.

PMID: 38509534 PMC: 10953148. DOI: 10.1186/s12958-024-01203-z.


Establishment and validation of a nomogram for subsequent first-cycle live births in patients diagnosed with recurrent implantation failure: a population-based analysis.

Zhang Y, Gong X, Zhang M, Zhu Y, Wang P, Wang Z Front Endocrinol (Lausanne). 2024; 15:1334599.

PMID: 38505751 PMC: 10950066. DOI: 10.3389/fendo.2024.1334599.